Evidence map›Paper›PMID 31612863›Full record

ArticleAging2019

Knockdown of

Yaxin Hu, Liangzhao Chu, Jian Liu, Lei Yu, Shi-Bin Song, Hua Yang, Feng Han

Open access · greenAbstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yaxin HuDepartment of Prenatal Diagnosis, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, China.
Liangzhao ChuDepartment of Cerebral Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, China.
Jian LiuDepartment of Cerebral Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, China.
Lei YuDepartment of Gynecology and Obstetrics, Guiyang Maternal and Child Health Hospital, Guiyang, Guizhou 550003, China.
Shi-Bin SongDepartment of Cerebral Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, China.
Hua YangDepartment of Cerebral Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, China.
Feng HanDepartment of Cerebral Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, China.
Affiliated Hospital of Guizhou Medical University · CNGuiyang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma is a highly malignant type of central nervous system tumor. In the present study, the results of RNA sequencing indicated that cAMP responsive element binding protein 3 (CREB3) was upregulated in tumor tissues from patients with GBM. The cAMP responsive element binding protein 3 (CREB3) pathway is a major contributor to the malignant progression of glioblastoma. In this study, we explored the mechanisms by which CREB3 regulates the proliferation, invasion and apoptosis of glioblastoma. Pairs of glioblastoma and normal tissues were subjected to RNA sequencing. Then, qRT-PCR and Western blotting were used to detect

Indexed as

AnimalsApoptosisAstrocytesBiomarkers, TumorCell LineCell ProliferationDown-RegulationEndoplasmic Reticulum StressFemaleGene Expression Regulation, NeoplasticGene Knockdown TechniquesGlioblastomaHumansMaleMiceMice, NudeBiomarkers, TumorapoptosiscAMP responsive element binding protein 3endoplasmic reticulum stressglioblastoma

Identifiers

PMID31612863
PMCPMC6814623
OpenAlexW2979658791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.